查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601253

放射性药物市场：按类型、技术和应用划分 - 2025-2030 年全球预测

Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年放射性药物市值为51.5亿美元，预计到2024年将达到54.8亿美元，复合年增长率为6.47%，预计到2030年将达到80亿美元。

放射性药物是用于医学领域的诊断、治疗和研究的放射性化合物。它在核子医学中发挥着极其重要的作用，主要用于诊断影像和治疗应用。对放射性药物的需求源于其靶向特定器官、组织和细胞受体的能力，使精确成像和有效治疗癌症、心血管疾病和神经系统疾病等疾病成为可能。最终用途主要是医院、诊断中心和专科诊所。影响成长的关键因素包括慢性病盛行率的增加、成像技术的进步以及老年人口的成长推动了对准确诊断工具和个人化治疗策略的需求。用于标靶治疗的放射性药物的快速发展，以及研发投资的增加，带来了巨大的商机。公司可以透过专注于利基适应症或开发具有成本效益和高效的生产方法来利用这些优势。

主要市场统计
基准年[2023] 51.5亿美元
预测年份 [2024] 54.8亿美元
预测年份 [2030] 80亿美元
复合年增长率（%） 6.47%

限制因素之一是处理放射性材料所固有的製造和监管合规性相关的高成本，这是进入和创新的障碍。此外，对先进基础设施和熟练人力资源的需求也增加了市场限制。智慧财产权障碍和冗长的核准流程使快速市场渗透变得更加复杂。

对功效更好、副作用更少的新同位素的研究有望促进业务成长。诊断影像技术的创新和新临床应用的开发可以为业务扩张铺平道路。他们也可能探索生技公司和医疗保健提供者之间的合作，以更有效地将放射性药物整合到现有的治疗框架中。

由于市场的高度监管和竞争性质，需要在研发方面进行大量投资才能保持竞争力。随着医疗保健政策的发展和技术的进步，关注新兴市场和开拓的应用程式可以让您快速适应这些变化并获得策略优势。

市场动态：揭示快速发展的放射性药物市场的关键市场洞察

供应和需求的动态交互作用正在改变放射性药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 目标疾病的发生率和盛行率增加
    • 基于α免疫疗法的标靶癌症治疗
    • 努力缩小Mo-99供需缺口
  • 市场限制因素
    • 缩短放射性药物的寿命
  • 市场机会
    • 放射性药物在神经学应用的采用
    • 诊断中心数量增加，特别是在新兴国家
  • 市场挑战
    • 设备价格高且医院预算有限

波特五力：驾驭放射性药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解放射性药物市场的外部影响

外部宏观环境因素在塑造放射性药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解放射性药物市场的竞争状况

放射性药物市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵放射性药物市场供应商绩效评估

FPNV定位矩阵是评估放射性药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 目标疾病的发生率和盛行率增加
      • 基于α放射免疫疗法的标靶癌症治疗
      • 努力缩小Mo-99供需缺口
    • 抑制因素
      • 放射性药物的寿命会缩短。
    • 机会
      • 放射性药物在神经学应用上的采用
      • 增加诊断中心，特别是在新兴国家
    • 任务
      • 设备价格高且医院预算有限
  • 市场区隔分析
    • 技能：近距离放射治疗手术的持续进步
    • 应用：提高放射性药物在治疗过程中的使用率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章放射性药物市场：依类型

  • 核医学诊断
    • 宠物放射性药物
      • F-18
      • Ru-82
    • Spect放射性药物
      • Ga-67
      • I-123
      • TC-99M
      • TL-201
  • 核子医学治疗
    • α发射体
    • β放射体
      • I-131
      • Lu-177
      • Re-186
      • SM-153
      • Y-90
    • 近距离放射治疗同位素
      • 铯131
      • I-125
      • 铱192
      • PD-103

第七章放射性药物市场：依技术分类

  • 诊断程序
    • 宠物放射性药物测试
    • Spect 放射性药物程序
  • 治疗程序
    • α发射体程序
    • β发射器程式
    • 近距离放射治疗程序

第八章放射性药物市场：依应用分类

  • 诊断用途
    • 宠物使用
      • 心臟病的指征
      • 神经适应
      • 肿瘤学适应症
    • 光谱使用
      • 心臟病学
      • 淋巴瘤
      • 神经病学
      • 甲状腺
  • 治疗用途
    • 骨转移
    • 内分泌肿瘤
    • 淋巴瘤治疗
    • 甲状腺治疗

第九章美洲放射性药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太放射性药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲放射性药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 百时美施贵宝透过收购 RaysBio 增加了一流的放射性药物平台
    • 新CRP开发新Technetium-99m放射性药物用于疾病诊断
    • 梅奥诊所支持的Start-Ups筹集了 5,600 万美元，瞄准放射性药物失败

公司名单

  • Global Medical Solutions
  • Siemens Healthineers AG
  • Fusion Pharmaceuticals Inc.
  • Novartis AG
  • International Isotopes, Inc.
  • Northstar Medical Technologies LLC
  • Institute of Isotopes Co. Ltd.
  • Jubilant Pharma Holdings Inc.
  • IsoTherapeutics Group, LLC
  • Eckert & Ziegler Group
  • Isotopia Molecular Imaging Ltd.
  • GE HealthCare Technologies, Inc.
  • BWX Technologies. Inc.
  • Clarity Pharmaceuticals
  • Eczacibasi-Monrol Nuclear Products Co.
  • Alliance Holdings Medical Limited
  • Cardinal Health, Inc.
  • Mallinckrodt PLC
  • Bracco Group
  • NTP Radioisotopes SOC Ltd.
  • Curium Pharma
  • Medi-Radiopharma
  • Sinotau Pharmaceutical Group
  • State Atomic Energy Corporation Rosatom
  • SHINE Medical Technologies
  • Lantheus Medical Imaging, Inc.
  • Bayer AG
  • BWXT Medical Ltd.
Product Code: MRR-4308E1C887A3

The Radiopharmaceuticals Market was valued at USD 5.15 billion in 2023, expected to reach USD 5.48 billion in 2024, and is projected to grow at a CAGR of 6.47%, to USD 8.00 billion by 2030.

Radiopharmaceuticals are radioactive compounds used for diagnosis, treatment, and research within the medical field. They play a pivotal role in nuclear medicine, primarily used in imaging and therapeutic applications. The necessity of radiopharmaceuticals stems from their ability to target specific organs, tissues, or cellular receptors, thereby enabling precise diagnostic imaging and effective treatment of diseases like cancer, cardiovascular ailments, and neurological disorders. End-use applications primarily involve hospitals, diagnostic centers, and specialized clinics. Key influencing growth factors include an increasing prevalence of chronic diseases, advancements in imaging technologies, and a growing geriatric population, which drives the demand for precise diagnostic tools and personalized treatment strategies. The rapid advancements in radiopharmaceuticals for targeted therapy, along with rising investment in research and development, present significant opportunities. Companies could capitalize on these by focusing on niche indications or developing cost-effective and efficient production methods.

KEY MARKET STATISTICS
Base Year [2023] USD 5.15 billion
Estimated Year [2024] USD 5.48 billion
Forecast Year [2030] USD 8.00 billion
CAGR (%) 6.47%

One limitation is the high cost related to the production and regulatory compliance inherent in handling radioactive materials, which poses a barrier to entry and innovation. Additionally, the need for sophisticated infrastructure and skilled personnel adds to market constraints. Intellectual property hurdles and a lengthy approval process further complicate rapid market penetration.

For business growth, research into new isotopes with better efficacy and lower side effects is promising. Innovation in imaging techniques and developing new clinical applications can pave the way for expansion. There is also potential in exploring collaborations between biotechnology firms and healthcare providers to integrate radiopharmaceuticals into existing treatment frameworks more effectively.

The nature of the market is highly regulated and competitive, with significant investments in R&D necessary for maintaining a competitive edge. As healthcare policies evolve and technology advances, adapting swiftly to these changes by focusing on emerging markets and untapped applications can provide strategic advantages.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radiopharmaceuticals Market

The Radiopharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Incidence and Prevalence of Target Conditions
    • Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
    • Initiatives To Reduce The Demand-Supply Gap of mo-99
  • Market Restraints
    • Shorter Life of Radiopharmaceuticals
  • Market Opportunities
    • Adoption of Radiopharmaceuticals in Neurological Applications
    • Rising Number of Diagnostic Centers Especially in Developing Countries
  • Market Challenges
    • High Equipment Prices and Limited Hospital Budget

Porter's Five Forces: A Strategic Tool for Navigating the Radiopharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radiopharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radiopharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radiopharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radiopharmaceuticals Market

A detailed market share analysis in the Radiopharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radiopharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radiopharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Radiopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Global Medical Solutions, Siemens Healthineers AG, Fusion Pharmaceuticals Inc., Novartis AG, International Isotopes, Inc., Northstar Medical Technologies LLC, Institute of Isotopes Co. Ltd., Jubilant Pharma Holdings Inc., IsoTherapeutics Group, LLC, Eckert & Ziegler Group, Isotopia Molecular Imaging Ltd., GE HealthCare Technologies, Inc., BWX Technologies. Inc., Clarity Pharmaceuticals, Eczacibasi-Monrol Nuclear Products Co., Alliance Holdings Medical Limited, Cardinal Health, Inc., Mallinckrodt PLC, Bracco Group, NTP Radioisotopes SOC Ltd., Curium Pharma, Medi-Radiopharma, Sinotau Pharmaceutical Group, State Atomic Energy Corporation Rosatom, SHINE Medical Technologies, Lantheus Medical Imaging, Inc., Bayer AG, and BWXT Medical Ltd..

Market Segmentation & Coverage

This research report categorizes the Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine is further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Pet Radiopharmaceuticals is further studied across F-18 and Ru-82. The Spect Radiopharmaceuticals is further studied across Ga-67, I-123, Tc-99m, and Tl-201. The Therapeutic Nuclear Medicine is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes. The Beta Emitters is further studied across I-131, Lu-177, Re-186, Sm-153, and Y-90. The Brachytherapy Isotopes is further studied across Cs-131, I-125, Ir-192, and Pd-103.
  • Based on Procedural Volume, market is studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures is further studied across Pet Radiopharmaceutical Procedure and Spect Radiopharmaceuticals Procedure. The Therapeutic Procedures is further studied across Alpha Emitter Procedure, Beta Emitters Procedure, and Brachytherapy Isotopes Procedure.
  • Based on Application, market is studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications is further studied across Pet Applications and Spect Applications. The Pet Applications is further studied across Cardiology Indication, Neurology Indication, and Oncology Indication. The Spect Applications is further studied across Cardiology, Lymphoma, Neurology, and Thyroid. The Therapeutic Applications is further studied across Bone Metastasis, Endocrine Tumors, Lymphoma Therapeutic, and Thyroid Therapeutic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence and Prevalence of Target Conditions
      • 5.1.1.2. Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
      • 5.1.1.3. Initiatives To Reduce The Demand-Supply Gap of mo-99
    • 5.1.2. Restraints
      • 5.1.2.1. Shorter Life of Radiopharmaceuticals
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of Radiopharmaceuticals in Neurological Applications
      • 5.1.3.2. Rising Number of Diagnostic Centers Especially in Developing Countries
    • 5.1.4. Challenges
      • 5.1.4.1. High Equipment Prices and Limited Hospital Budget
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Procedural Volume: Ongoing advancements in brachytherapy isotopes procedure
    • 5.2.2. Application: Increasing utilization of radiopharmaceuticals in therapeutic procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Radiopharmaceuticals Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostic Nuclear Medicine
    • 6.2.1. Pet Radiopharmaceuticals
      • 6.2.1.1. F-18
      • 6.2.1.2. Ru-82
    • 6.2.2. Spect Radiopharmaceuticals
      • 6.2.2.1. Ga-67
      • 6.2.2.2. I-123
      • 6.2.2.3. Tc-99m
      • 6.2.2.4. Tl-201
  • 6.3. Therapeutic Nuclear Medicine
    • 6.3.1. Alpha Emitters
    • 6.3.2. Beta Emitters
      • 6.3.2.1. I-131
      • 6.3.2.2. Lu-177
      • 6.3.2.3. Re-186
      • 6.3.2.4. Sm-153
      • 6.3.2.5. Y-90
    • 6.3.3. Brachytherapy Isotopes
      • 6.3.3.1. Cs-131
      • 6.3.3.2. I-125
      • 6.3.3.3. Ir-192
      • 6.3.3.4. Pd-103

7. Radiopharmaceuticals Market, by Procedural Volume

  • 7.1. Introduction
  • 7.2. Diagnostic Procedures
    • 7.2.1. Pet Radiopharmaceutical Procedure
    • 7.2.2. Spect Radiopharmaceuticals Procedure
  • 7.3. Therapeutic Procedures
    • 7.3.1. Alpha Emitter Procedure
    • 7.3.2. Beta Emitters Procedure
    • 7.3.3. Brachytherapy Isotopes Procedure

8. Radiopharmaceuticals Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Applications
    • 8.2.1. Pet Applications
      • 8.2.1.1. Cardiology Indication
      • 8.2.1.2. Neurology Indication
      • 8.2.1.3. Oncology Indication
    • 8.2.2. Spect Applications
      • 8.2.2.1. Cardiology
      • 8.2.2.2. Lymphoma
      • 8.2.2.3. Neurology
      • 8.2.2.4. Thyroid
  • 8.3. Therapeutic Applications
    • 8.3.1. Bone Metastasis
    • 8.3.2. Endocrine Tumors
    • 8.3.3. Lymphoma Therapeutic
    • 8.3.4. Thyroid Therapeutic

9. Americas Radiopharmaceuticals Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Radiopharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Radiopharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
    • 12.3.2. New CRP to Develop new Technetium-99m Radiopharmaceuticals for Disease Diagnosis
    • 12.3.3. With USD 56 Million, a Mayo Clinic-backed Startup takes aim at Radiopharmaceutical Roadblocks

Companies Mentioned

  • 1. Global Medical Solutions
  • 2. Siemens Healthineers AG
  • 3. Fusion Pharmaceuticals Inc.
  • 4. Novartis AG
  • 5. International Isotopes, Inc.
  • 6. Northstar Medical Technologies LLC
  • 7. Institute of Isotopes Co. Ltd.
  • 8. Jubilant Pharma Holdings Inc.
  • 9. IsoTherapeutics Group, LLC
  • 10. Eckert & Ziegler Group
  • 11. Isotopia Molecular Imaging Ltd.
  • 12. GE HealthCare Technologies, Inc.
  • 13. BWX Technologies. Inc.
  • 14. Clarity Pharmaceuticals
  • 15. Eczacibasi-Monrol Nuclear Products Co.
  • 16. Alliance Holdings Medical Limited
  • 17. Cardinal Health, Inc.
  • 18. Mallinckrodt PLC
  • 19. Bracco Group
  • 20. NTP Radioisotopes SOC Ltd.
  • 21. Curium Pharma
  • 22. Medi-Radiopharma
  • 23. Sinotau Pharmaceutical Group
  • 24. State Atomic Energy Corporation Rosatom
  • 25. SHINE Medical Technologies
  • 26. Lantheus Medical Imaging, Inc.
  • 27. Bayer AG
  • 28. BWXT Medical Ltd.

LIST OF FIGURES

  • FIGURE 1. RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. RADIOPHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RADIOPHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 174. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 176. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 178. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 180. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 184. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 191. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 192. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 193. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 194. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 202. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 206. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 207. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 208. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 209. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 210. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 211. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 212. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 213. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 214. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 218. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 219. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 221. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 222. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 223. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 224. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 225. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 226. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 227. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 228. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 229. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 236. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 237. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 238. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 239. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 240. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 241. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 242. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 243. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 244. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 247. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 251. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 252. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 253. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 254. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 255. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 256. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 257. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 258. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 259. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 261. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 263. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 266. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 268. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 270. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 272. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 274. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 278. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 281. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 282. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 283. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 284. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 285. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 286. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 287. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 288. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 289. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 291. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 293. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 296. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 298. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 300. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 302. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 304. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 306. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 307. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 308. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 309. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 311. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 312. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 313. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 314. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
  • TABLE 315. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
  • TABLE 316. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
  • TABLE 317. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 318. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 319. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 321. TAIWAN RADI